Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Conditions
Interventions
Apitox, purified honeybee toxin, lyophilized in saline
histamine
Locations
15
United States
Functional Research LLC
Gulf Shores, Alabama, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
SC Clinical Research Inc.
Garden Grove, California, United States
Axis Clinical Trials
Los Angeles, California, United States
Westlake Medical Research
Thousand Oaks, California, United States
SC Clinical Research Inc.
Upland, California, United States
Start Date
December 1, 2013
Primary Completion Date
November 1, 2016
Completion Date
December 1, 2016
Last Updated
December 13, 2016
NCT06927934
NCT01820650
NCT04145011
NCT01899508
NCT03349645
NCT04882319
Lead Sponsor
Apimeds, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions